entertainment -WSS

entertainment

author：comprehensive 2025-10-03 19:57:09 - browse：89

Metastatic Melanoma Cells – cancer research coverage from STAT — Metastatic melanoma cells NCI/NIH

Cancer drugs can burn through tumors like a wildfire, killing off the vast majority of malignant cells. But a few stubborn cells often end up surviving, seeding a recurrence of the disease. The prevailing theory behind this drug resistance is built on natural selection: Among the vast and genetically diverse population of cancer cells in a tumor, some have random mutations that help these cells survive an onslaught.

“But this is not the full picture,” said Yogesh Goyal, a cancer researcher at Northwestern University. Goyal and his colleagues at the University of Pennsylvania demonstrated in a series of experiments that cancer cells can survive treatments just by having certain genes turned on, even if they were nearly genetically identical to cancer cells that died but had activated different genes.

“We think this work stands to really change how we think about therapy resistance,” said Arjun Raj, the study’s co-senior author and a bioengineer at the University of Pennsylvania.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Readout LOUD podcast: Merger Mondays, Ozempic panic

WSS

European regulators recommend Amylyx's ALS drug be rejected

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Cloning humans is technically possible. It's curious no one has tried

The strategy behind pharma's lawsuits over drug pricing reform

Paxlovid study fails to answer questions over benefit for broader groups

STAT's guide to the next generation of CAR

entertainment

entertainment

knowledge

Peter Hotez and the public health issue of online harassment

Female surgeons have lower rates of long

Malaria cases in Florida and Texas: Here’s what you need to know

Weight bias in eating disorder treatment complicated by new weight loss drugs

Apple is now the first public company to be valued at $3 trillion

The science behind Janet Jackson's pregnancy at 49

Tori Bowie and the unacceptable rates of Black maternal death

A fraught question for the kids of Alzheimer’s: Is it coming for us?

The high cost of giving birth even with insurance

There’s no way to know how good AI health technologies are

explore

WATCH: Why do fingernails fall off when they're damaged?

With FDA staff opposed to Sarepta therapy, top official intervened

Readout LOUD podcast: Merger Mondays, Ozempic panic

How should state employee insurance handle Wegovy?

Paxlovid study fails to answer questions over benefit for broader groups

Ask STAT: What do you want to know about ChatGPT in medicine?

focus

focus

hotspot

focus